Eradicating the Roots: Advanced Therapeutic Approaches Targeting Breast Cancer Stem Cells

Author(s): Lili He, Anran Yu, Li Deng, Hongwei Zhang*.

Journal Name: Current Pharmaceutical Design

Volume 26 , Issue 17 , 2020

Become EABM
Become Reviewer


Accumulating evidences have demonstrated that the existence of breast cancer-initiating cells, which drives the original tumorigenicity, local invasion and migration propensity of breast cancer. These cells, termed as breast cancer stem cells (BCSCs), possess properties including self-renewal, multidirectional differentiation and proliferative potential, and are believed to play important roles in the intrinsic drug resistance of breast cancer. One of the reasons why BCBCs cause difficulties in breast cancer treating is that BCBCs can control both genetic and non-genetic elements to keep their niches safe and sound, which allows BCSCs for constant self-renewal and differentiation. Therapeutic strategies designed to target BCSCs may ultimately result in effective interventions for the treatment of breast cancer. Novel strategies including nanomedicine, oncolytic virus therapy, immunotherapy and induced differentiation therapy are emerging and proved to be efficient in anti-BCSCs therapy. In this review, we summarized breast tumor biology and the current challenges of breast cancer therapies, focused on breast cancer stem cells, and introduced promising therapeutic strategies targeting BCSCs.

Keywords: Breast cancer stem cells, immunotherapy, nanomedicine, oncolytic virus therapy, breast tumor, targeted therapy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Page: [2009 - 2021]
Pages: 13
DOI: 10.2174/1381612826666200317132949
Price: $65

Article Metrics

PDF: 12